Not Only Against Cytomegalovirus - Combined Prophylaxis with Antivirals and Specific Immunoglobulins Reduces Acute Rejection Rates

被引：0
|
作者：
Fanetti, M. [1 ]
Messina, M. [1 ]
Perillo, F. [1 ]
Luzzi, L. [1 ]
Paladini, P. [1 ]
Franchi, F. [1 ]
Montagnani, F. [1 ]
Bargagli, E. [1 ]
Fossi, A. [1 ]
Bennett, D. [1 ]
机构：
[1] Univ Hosp Siena, Siena, Italy
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1024
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 44 条
  • [1] Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection
    Reischig, T
    Jindra, P
    Mares, J
    Cechura, M
    Svecová, M
    Hes, O
    Opatrny, K
    Treska, V
    TRANSPLANTATION, 2005, 79 (03) : 317 - 324
  • [2] Combined cytomegalovirus prophylaxis in lung transplantation: Effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections
    Solidoro, P.
    Libertucci, D.
    Delsedime, L.
    Ruffini, E.
    Bosco, M.
    Costa, C.
    Rinaldi, M.
    Baldi, S.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) : 2013 - 2014
  • [3] Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection: A randomized comparison with oral ganciclovir and deferred therapy
    Reischig, T
    Jindra, P
    Mares, J
    Opatrny, K
    Treska, V
    Cechura, M
    Svecova, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 493 - 493
  • [4] Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection
    Potena, L.
    Holweg, C.
    Luikart, H.
    Mocarski, E.
    Lewis, D.
    Cooke, J.
    Chin, C.
    Hunt, S.
    Valantine, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S117 - S118
  • [5] INCIDENCE OF INFECTION AND ACUTE REJECTION AFTER CYTOMEGALOVIRUS IMMUNE GLOBULIN PROPHYLAXIS IN RENAL-TRANSPLANTATION
    BASADONNA, G
    FERIA, A
    PEREZ, R
    KLEIN, H
    STURGES, M
    COLQUHOUN, S
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 52 - 53
  • [6] Universal Valganciclovir Prophylaxis Significantly Reduces Episodes of First-Year Cytomegalovirus Disease and Biopsy-Proven Acute Rejection in Kidney Transplant Recipients
    Tu, P. T.
    Shu, K. H.
    Cheng, C. H.
    Chen, C. H.
    Yu, T. M.
    Chuang, Y. W.
    Huang, S. T.
    Tsai, S. F.
    Cheng, C. Y.
    Wu, M. J.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (02) : 574 - 577
  • [7] Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era?
    Luckraz, H
    Charman, SC
    Wreghitt, T
    Wallwork, J
    Parameshwar, J
    Large, SR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (09): : 1023 - 1027
  • [8] Rituximab prophylaxis reduces acute rejection risk in pre-sensitized renal allograft recipients
    Dadhania, D.
    Sharma, V.
    Friedlander, R.
    Wang, K.
    Aull, M.
    Menon, A.
    Seshan, S.
    Fotino, M.
    Suthanthiran, M.
    HUMAN IMMUNOLOGY, 2007, 68 : S118 - S118
  • [9] Valacyclovir prophylaxis for cytomegalovirus is associated with reduced risk of acute renal allograft rejection compared to preemptive valganciclovir therapy
    Reischig, Tomas
    Jindra, Pavel
    Klaboch, Jan
    Svecova, Miroslava
    Hes, Ondrej
    Treska, Vladislav
    TRANSPLANT INTERNATIONAL, 2007, 20 : 185 - 185
  • [10] COMBINED ANTIVIRAL AND IMMUNOGLOBULIN THERAPY AS PROPHYLAXIS AGAINST CYTOMEGALOVIRUS-INFECTION AFTER HEART-TRANSPLANTATION
    VALENZA, M
    CZER, LSC
    PAN, SH
    ALEKSIC, I
    FREIMARK, D
    HARASTY, DA
    ADMON, D
    BARATH, P
    BLANCHE, C
    TRENTO, A
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1995, 14 (04): : 659 - 665
12345